News
INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y
Inogen, Inc. INGN incurred an adjusted loss per share of 11 cents for first-quarter 2025, which was narrower than the adjusted loss per share of 45 cents in the year-ago period and the Zacks
Baidu Stock Trades 25% Below 52-Week High: Should You Buy the Dip?
Baidu, Inc. BIDU shares have gained 7.8% in the past month, above the Zacks Internet – Services industry’s 3.4% increase and the Zacks Computer and Technology sector’s rise of 4.5%. Despite this
Guaranty Bancshares (GNTY) Upgraded to Strong Buy: Here's What You Should Know
Guaranty Bancshares Inc. (GNTY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings
All You Need to Know About Alexander's (ALX) Rating Upgrade to Strong Buy
Alexander's (ALX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one
Acadian Asset Management (AAMI) Upgraded to Buy: What Does It Mean for the Stock?
Acadian Asset Management (AAMI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates
What Makes Veracyte (VCYT) a New Buy Stock
Veracyte (VCYT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why
LifeStance Health Group (LFST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings
Monro (MNRO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Monro Muffler Brake (MNRO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
Dynavax Technologies (DVAX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings
Novo Nordisk (NVO) Upgraded to Buy: Here's What You Should Know
Novo Nordisk (NVO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one
Fidelity National (FIS) Upgraded to Buy: What Does It Mean for the Stock?
Fidelity National Information Services (FIS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful
What Makes Stag (STAG) a New Buy Stock
Stag Industrial (STAG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of
Are You Looking for a Top Momentum Pick? Why Trane Technologies (TT) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
TTM Technologies (TTMI) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
Are You Looking for a Top Momentum Pick? Why Paymentus (PAY) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
Are You Looking for a Top Momentum Pick? Why New Gold (NGD) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
What Makes BioCryst Pharmaceuticals (BCRX) a Strong Momentum Stock: Buy Now?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell
Are You Looking for a Top Momentum Pick? Why Intesa Sanpaolo SpA (ISNPY) is a Great Choice
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even
Occidental Petroleum Q1 Earnings Surpass Estimates, Revenues Rise Y/Y
Occidental Petroleum Corporation OXY reported first-quarter 2025 earnings of 87 cents per share, which surpassed the Zacks Consensus Estimate of 73 cents by 19.2%. The bottom line improved 38.1%
UBS Group to Pay $511M to Settle Credit Suisse Tax Evasion Case
UBS Group AG UBS agreed to pay $511 million to resolve a tax probe by the U.S. Department of Justice (“DOJ”) against Credit Suisse for preparing false income tax returns and tax evasion. UBS Group
Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?
DaVita Inc. DVA is scheduled to report first-quarter 2025 results on May 12, after the closing bell.
In the last reported quarter, the company’s earnings per share (EPS) of $2.24 beat the Zacks
XRAY Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
DENTSPLY SIRONA Inc. XRAY reported first-quarter 2025 adjusted earnings per share (EPS) of 43 cents, up by a penny year over year. The bottom line surpassed the Zacks Consensus Estimate by 48.3%
What to Expect From Simon Property Stock This Earnings Season?
Simon Property Group SPG is slated to report first-quarter 2025 results on May 12, after market close. While the company’s quarterly results are likely to display a year-over-year rise in revenues


